These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8541395)

  • 1. Biologic therapies for gynecologic cancer.
    Bookman MA
    Curr Opin Oncol; 1995 Sep; 7(5):478-84. PubMed ID: 8541395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapy of ovarian cancer: current directions.
    Bookman MA
    Semin Oncol; 1998 Jun; 25(3):381-96. PubMed ID: 9633851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological therapy for gynecologic malignancies.
    Bookman MA
    Cancer Treat Res; 1998; 95():115-47. PubMed ID: 9619282
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic and immunologic therapy of ovarian cancer.
    Bookman MA; Berek JS
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):941-65. PubMed ID: 1500395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapy and immunotherapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1991 Oct; 3(5):901-7. PubMed ID: 1751581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies used in the detection and treatment of epithelial ovarian cancer.
    Muto MG; Kassis AI
    Cancer; 1995 Nov; 76(10 Suppl):2016-27. PubMed ID: 8634994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy for the treatment of malignant common epithelial tumors of the ovary.
    Hamilton TC; Ozols RF; Longo DL
    Cancer; 1987 Oct; 60(8 Suppl):2054-63. PubMed ID: 2443236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and therapy with biologic agents in gynecologic cancer.
    Wiener JR; Berchuck A; Bast RC
    Curr Opin Oncol; 1992 Oct; 4(5):946-54. PubMed ID: 1457511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1990 Oct; 2(5):893-900. PubMed ID: 2095893
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic and immunologic therapies for ovarian cancer.
    Berek JS; Schultes BC; Nicodemus CF
    J Clin Oncol; 2003 May; 21(10 Suppl):168s-174s. PubMed ID: 12743131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1989 Oct; 1(1):112-8. PubMed ID: 2489941
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotherapy of ovarian cancer.
    Lidor Y; Bast RC
    Nat Immun Cell Growth Regul; 1988; 7(4):193-215. PubMed ID: 3070370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Aug; 26(4 Suppl 12):41-50. PubMed ID: 10482193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies in the management of ovarian cancer. A clinical perspective.
    Rubin SC
    Cancer; 1993 Feb; 71(4 Suppl):1602-12. PubMed ID: 8431896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunobiology and immunotherapy of ovarian cancer.
    Bookman MA; Bast RC
    Semin Oncol; 1991 Jun; 18(3):270-91. PubMed ID: 1710393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in monoclonal antibody therapy of cancer.
    LoBuglio AF; Saleh MN
    Am J Med Sci; 1992 Sep; 304(3):214-24. PubMed ID: 1476160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-drug conjugates for cancer therapy.
    Carter PJ; Senter PD
    Cancer J; 2008; 14(3):154-69. PubMed ID: 18536555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors.
    De Felice F; Marchetti C; Palaia I; Musio D; Muzii L; Tombolini V; Panici PB
    J Immunol Res; 2015; 2015():191832. PubMed ID: 26236750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of monoclonal antibodies in gynecologic oncology.
    Smith LH; Teng NN
    Cancer; 1987 Oct; 60(8 Suppl):2068-74. PubMed ID: 3308066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of inflammatory dermatoses with novel biologic agents: a primer.
    Nussbaum R; Krueger JG
    Adv Dermatol; 2002; 18():45-89. PubMed ID: 12528402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.